tiprankstipranks
Trending News
More News >
Psyence Biomedical (PBM)
NASDAQ:PBM
US Market

Psyence Biomedical (PBM) Income Statement

Compare
217 Followers

Psyence Biomedical Income Statement

Last quarter (Q3 2023), Psyence Biomedical's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Psyence Biomedical's net income was C$-24.76M. See Psyence Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -4.27KC$ -240.00C$ 0.00C$ 0.00
Operating Expenses
C$ 3.66MC$ 2.75MC$ 1.29MC$ 334.29K
Depreciation and Amortization
C$ 4.27KC$ 240.00C$ 0.00C$ 0.00
EBITDA
C$ 1.03MC$ -51.11MC$ -1.29MC$ -334.29K
Operating Income
C$ -3.66MC$ -2.75MC$ -1.29MC$ -334.29K
Other Income/Expenses
C$ 4.67MC$ -48.41MC$ 9.31MC$ 8.56M
Pretax Income
C$ 1.01MC$ -51.16MC$ 8.01MC$ 8.23M
Net Income
C$ 1.01MC$ -51.16MC$ 8.01MC$ 8.23M
Per Share Metrics
Basic EPS
C$ 1.78C$ -7.85C$ -0.64C$ 0.25
Diluted EPS
C$ 1.78C$ -7.85C$ -0.64C$ 0.25
Weighted Average Shares Outstanding
568.02K 6.52M 32.67M 32.67M
Weighted Average Shares Outstanding (Diluted)
568.02K 6.52M 32.67M 32.67M
Currency in CAD

Psyence Biomedical Earnings and Revenue History